Prevention of Thrombocytopenia and Thrombosis in Heparin-Induced Thrombocytopenia (HIT) Using Deglycosylated KKO: A Novel Therapeutic for HIT? Prevention of Thrombocytopenia and Thrombosis in Heparin-Induced Thrombocytopenia (HIT) Using Deglycosylated KKO: A Novel Therapeutic for HIT? Haemin Go / Tuesday, July 20, 2021 0 743 Article rating: No rating Tuesday, July 20, 2021 On Tuesday, July 20, 2021, Amrita Sarkar, Ph.D., of the University of Pennsylvania and Children's Hospital of Philadelphia in Philadelphia presented research about heparin-induced thrombocytopenia (HIT) and a potential new therapeutic. Read more
Oral Pazopanib Results in Durable Hemostasis in Patients with Severe Bleeding and RBC Transfusion-dependent Hereditary Hemorrhagic Telangiectasia Oral Pazopanib Results in Durable Hemostasis in Patients with Severe Bleeding and RBC Transfusion-dependent Hereditary Hemorrhagic Telangiectasia Haemin Go / Tuesday, July 20, 2021 0 831 Article rating: No rating Tuesday, July 20, 2021 On Tuesday, July 20, 2021, Hanny Al-Samkari, M.D., of Massachusetts General Hospital in Boston presented results on oral pazopanib for severe hereditary hemorrhagic telangiectasia (HHT)-associated bleeding. Read more
VEGF and Vascular Permeability VEGF and Vascular Permeability Haemin Go / Tuesday, July 20, 2021 0 667 Article rating: No rating Tuesday, July 20, 2021 To find new drug targets for leakage prevention, Lena Claesson-Welsh and her coworkers have delineated the signaling pathway induced by VEGF. Read more
What Impact Is World Thrombosis Day Making Around the Globe? What Impact Is World Thrombosis Day Making Around the Globe? Haemin Go / Tuesday, July 20, 2021 0 1185 Article rating: No rating Tuesday, July 20, 2021 Read more